Short Incubation Methylaminolevulinate Photodynamic Therapy Without Occlusion
Phase 3
Completed
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Methylaminolevulinate (Metvix, Metvixia)Device: Photodynamic Therapy (Aktilite)
- First Posted Date
- 2009-06-24
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT00926952
- Locations
- 🇨🇦
Innovaderm Research Inc, Montreal, Quebec, Canada
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT00640393
- Locations
- 🇨🇦
Bank on Beauty, Niagara Falls, Ontario, Canada
🇨🇦Innovaderm Research Inc., Montreal, Quebec, Canada
🇨🇦Winnipeg Clinic, Winnipeg, Manitoba, Canada
Safety and Efficacy of Infliximab in Palmoplantar Psoriasis
- First Posted Date
- 2008-03-06
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00629772
- Locations
- 🇨🇦
Lynderm Research Inc., Markham, Ontario, Canada
🇨🇦Innovaderm Research Laval, Laval, Quebec, Canada
🇨🇦The Guenther Dermatology Research Center, London, Ontario, Canada
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
Phase 3
Completed
- Conditions
- Palmoplantaris Pustulosis
- Interventions
- Drug: Placebo comparator
- First Posted Date
- 2006-07-17
- Last Posted Date
- 2011-09-09
- Lead Sponsor
- Innovaderm Research Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT00353119
- Locations
- 🇨🇦
Innovaderm Research Incorporated, Montreal, Quebec, Canada
🇨🇦Centre de Recherche Dermatologique du Québec métropolitain, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath